Fundraising FoxEmpresstx
1 known investors
Find your way into Empresstx
Sign up to see every warm intro you have to Empresstx
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Empresstx team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Empress provides drug discovery teams with an industrialized Perturb-seq platform that combines CRISPR-based single-cell functional genomics, chemoproteomics, and multi-omics with causal machine learning to identify what drives activity, efficacy, and risk. It serves pharmaceutical and biotech R&D teams seeking mechanistic understanding of drug targets.
Investors · 1
Frequently asked questions
- What does Empresstx do?
- Empress provides drug discovery teams with an industrialized Perturb-seq platform that combines CRISPR-based single-cell functional genomics, chemoproteomics, and multi-omics with causal machine learning to identify what drives activity, efficacy, and risk. It serves pharmaceutical and biotech R&D teams seeking mechanistic understanding of drug targets.
- Who are Empresstx's investors?
- Empresstx's investors include J2 Ventures.